193 related articles for article (PubMed ID: 9824261)
1. HGV/GBV-C infection in liver transplant recipients: antibodies to the viral E2 envelope glycoprotein protect from de novo infection.
Silini E; Belli L; Alberti AB; Asti M; Cerino A; Bissolati M; Rondinara G; De Carlis L; Forti D; Mondelli MU; Ideo G
J Hepatol; 1998 Oct; 29(4):533-40. PubMed ID: 9824261
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection.
Tillmann HL; Heringlake S; Trautwein C; Meissner D; Nashan B; Schlitt HJ; Kratochvil J; Hunt J; Qiu X; Lou SC; Pichlmayr R; Manns MP
Hepatology; 1998 Aug; 28(2):379-84. PubMed ID: 9696000
[TBL] [Abstract][Full Text] [Related]
3. GB virus C (GBV-C/HGV) and E2 antibodies in children preliver and postliver transplant.
Elkayam O; Hassoba HM; Ferrell LD; Garcia-Kennedy R; Gish RG; Wright TL; Laffler T; Traylor D; Hunt G; Rosenthal P
Pediatr Res; 1999 Jun; 45(6):795-8. PubMed ID: 10367767
[TBL] [Abstract][Full Text] [Related]
4. Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA and those with GBV-C/HGV E2-antibody in patients with hemophilia.
Toyoda H; Takahashi I; Fukuda Y; Hayakawa T; Takamatsu J
J Med Virol; 2000 Jan; 60(1):34-8. PubMed ID: 10568760
[TBL] [Abstract][Full Text] [Related]
5. Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation.
Bizollon T; Guichard S; Ahmed SN; Chevallier P; Ducerf C; Sepetjan M; Baulieux J; Trepo C
J Hepatol; 1998 Dec; 29(6):893-900. PubMed ID: 9875635
[TBL] [Abstract][Full Text] [Related]
6. Antienvelope antibodies are protective against GBV-C reinfection: evidence from the liver transplant model.
Hassoba HM; Pessoa MG; Terrault NA; Lewis NJ; Hayden M; Hunt JC; Qiu X; Lou SC; Wright TL
J Med Virol; 1998 Nov; 56(3):253-8. PubMed ID: 9783694
[TBL] [Abstract][Full Text] [Related]
7. Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis.
Tanaka E; Kiyosawa K; Shimoda K; Hino K; Tacke M; Schmolke S; Engel AM; Hess G
J Viral Hepat; 1998 May; 5(3):153-9. PubMed ID: 9658367
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.
Bourlet T; Guglielminotti C; Evrard M; Berthelot P; Grattard F; Frésard A; Lucht FR; Pozzetto B
J Med Virol; 1999 Aug; 58(4):373-7. PubMed ID: 10421404
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
Hwang SJ; Lu RH; Chan CY; Chang FY; Lee SD
J Med Virol; 1999 Jan; 57(1):85-9. PubMed ID: 9890427
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.
Desassis JF; Laperche S; Girault A; Kolko A; Bouchardeau F; Zins B; Poignet JL; Couroucé AM
Nephrol Dial Transplant; 1999 Nov; 14(11):2692-7. PubMed ID: 10534514
[TBL] [Abstract][Full Text] [Related]
11. Risk and clearance of GB virus C/hepatitis G virus infection in homosexual men: A longitudinal study.
Stark K; Doering CD; Bienzle U; Pauli G; Hamouda O; Engel AM; Schreier E
J Med Virol; 1999 Nov; 59(3):303-6. PubMed ID: 10502260
[TBL] [Abstract][Full Text] [Related]
12. GB virus C/hepatitis G viremia and antibody response to the E2 protein of hepatitis G virus in hemodialysis patients.
Okuda M; Hino K; Korenaga M; Yamaguchi Y; Katoh Y; Mukaide M; Kaneda Y; Minaminozono T; Okita K
J Clin Gastroenterol; 2000 Jun; 30(4):425-8. PubMed ID: 10875473
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of GB virus C/hepatitis G virus ribonucleic acid and anti-hepatitis G virus-E2 antibodies among Japanese children with histories of transfusions or with liver diseases.
Goto K; Sugiyama K; Li R; Miyake Y; Ando T; Mizutani F; Terabe K; Mizuno K; Wada Y
Pediatr Res; 1999 Jan; 45(1):128-32. PubMed ID: 9890620
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis.
Sheng L; Widyastuti A; Kosala H; Donck J; Vanrenterghem Y; Setijoso E; Soumillion A; Verslype C; Schelstraete R; Emonds MP; Hess G; Yap SH
Am J Kidney Dis; 1998 Feb; 31(2):218-23. PubMed ID: 9469490
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of hepatitis G virus RNA and antibodies to HGV envelope protein (anti-E2) in patients with liver injury in Japan].
Matsushita E; Kaneko S; Kobayashi K
Nihon Rinsho; 1999 Jun; 57(6):1274-8. PubMed ID: 10390982
[TBL] [Abstract][Full Text] [Related]
16. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa.
Sathar MA; Soni PN; Naicker S; Conradie J; Lockhat F; Gouws E
J Med Virol; 1999 Sep; 59(1):38-44. PubMed ID: 10440806
[TBL] [Abstract][Full Text] [Related]
17. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis.
Tribl B; Schöniger-Hekele M; Petermann D; Bakos S; Penner E; Müller C
Am J Gastroenterol; 1999 Nov; 94(11):3336-40. PubMed ID: 10566740
[TBL] [Abstract][Full Text] [Related]
19. Profiles of GBV-C/hepatitis G virus markers in patients coinfected with hepatitis C virus.
Sauleda S; Reesink HJ; Esteban JI; Hess G; Esteban R; Guardia J
J Med Virol; 1999 Sep; 59(1):45-51. PubMed ID: 10440807
[TBL] [Abstract][Full Text] [Related]
20. GB virus C/hepatitis G virus infection in hemodialysis patients: determination of seroprevalence by a four-antigen recombinant immunoblot assay.
Schröter M; Feucht HH; Schäfer P; Zöllner B; Laufs R
J Med Virol; 1999 Mar; 57(3):230-4. PubMed ID: 10022792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
